UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 174

Sortiert nach

Cytokines and Chemokines in Neuromyelitis Optica: Pathogenetic and Therapeutic Implications

Brain pathology (Zurich, Switzerland), 2014-01, Vol.24 (1), p.67-73

2014

Volltextzugriff (PDF)

Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey

Multiple sclerosis, 2023-04, Vol.29 (4-5), p.530-539

2023

Volltextzugriff (PDF)

Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder

Journal of neurology, neurosurgery and psychiatry, 2022-01, Vol.93 (1), p.32

2022

Volltextzugriff (PDF)

Long-term outcomes and prognostic factors in generalized myasthenia gravis

Journal of neurology, 2021-10, Vol.268 (10), p.3781-3788

2021

Volltextzugriff (PDF)

Complete Relief of Painful Tonic Seizures in Neuromyelitis Optica Spectrum Disorder by Satralizumab Treatment

Internal Medicine, 2022/09/15, Vol.61(18), pp.2785-2787

2022

Volltextzugriff (PDF)

Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disorders

Journal of neurology, 2022-04, Vol.269 (4), p.1996-2003

2022

Volltextzugriff (PDF)

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

Multiple sclerosis, 2010-12, Vol.16 (12), p.1443-1452

2010

Volltextzugriff (PDF)

Soluble CD40 ligand contributes to blood–brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder

Journal of neuroimmunology, 2017-04, Vol.305, p.102-107

2017

Volltextzugriff (PDF)

Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis

PloS one, 2020-04, Vol.15 (4), p.e0224419

2020

Volltextzugriff (PDF)

The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert–Eaton myasthenic syndrome

Clinical & experimental neuroimmunology, 2023-02, Vol.14 (1), p.19-27

2023

Volltextzugriff (PDF)

“Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis

Multiple sclerosis, 2014-03, Vol.20 (3), p.331-337

2014

Volltextzugriff (PDF)

Delayed Appearance of Brain Magnetic Resonance Imaging Abnormalities in a Patient with Glial Fibrillary Acidic Protein Astrocytopathy

Internal Medicine, 2023/02/01, Vol.62(3), pp.465-468

2023

Volltextzugriff (PDF)

Temporal Changes in Brain Perfusion in a Patient with Myoclonus and Ataxia Syndrome Associated with COVID-19

Internal Medicine, 2022/04/01, Vol.61(7), pp.1071-1076

2022

Volltextzugriff (PDF)

Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis

Journal of the neurological sciences, 2019-01, Vol.396, p.8-11

2019

Volltextzugriff (PDF)

Response to “regarding the article ‘Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis’”

Journal of the neurological sciences, 2019-04, Vol.399, p.229-229

2019

Volltextzugriff (PDF)

Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis optica

Clinica chimica acta, 2017-06, Vol.469, p.144-149

2017

Volltextzugriff (PDF)

Split hand and motor axonal hyperexcitability in spinal and bulbar muscular atrophy

Journal of neurology, neurosurgery and psychiatry, 2020-11, Vol.91 (11), p.1189

2020

Volltextzugriff (PDF)

Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD

Scientific reports, 2023-03, Vol.13 (1), p.3538-3538, Article 3538

2023

Volltextzugriff (PDF)

Efficacy of high-dose intravenous methylprednisolone therapy for ocular myasthenia gravis

Journal of the neurological sciences, 2019-07, Vol.402, p.12-15

2019

Volltextzugriff (PDF)

Serum high mobility group box 1 is upregulated in myasthenia gravis

Journal of neurology, neurosurgery and psychiatry, 2015-06, Vol.86 (6), p.695-697

2015

Volltextzugriff (PDF)

Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis

Therapeutic advances in neurological disorders, 2020, Vol.13, p.1756286420904207-1756286420904207

2020

Volltextzugriff (PDF)

Frontal deficits and atrophy in a patient with familial encephalopathy with neuroserpin inclusion bodies detected by single-case voxel-based morphometry: a case report

BMC neurology, 2024-01, Vol.24 (1), p.9-9, Article 9

2024

Volltextzugriff (PDF)

Geographical differences in preventative therapies for neuromyelitis optica spectrum disorder

Journal of neurology, neurosurgery and psychiatry, 2017-08, Vol.88 (8), p.620

2017

Volltextzugriff (PDF)

Soluble CD40 ligand disrupts the blood–brain barrier and exacerbates inflammation in experimental autoimmune encephalomyelitis

Journal of neuroimmunology, 2018-03, Vol.316, p.117-120

2018

Volltextzugriff (PDF)

1 – 25 von 174

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(154)

Publikationsform

Artikel
(167)
Berichte
(7)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Cytokines and Chemokines in Neuromyelitis Optica: Pathogenetic and Therapeutic Implications

Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey

Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder

Long-term outcomes and prognostic factors in generalized myasthenia gravis

Complete Relief of Painful Tonic Seizures in Neuromyelitis Optica Spectrum Disorder by Satralizumab Treatment

Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disorders

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

Soluble CD40 ligand contributes to blood–brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder

Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis

The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert–Eaton myasthenic syndrome

“Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis

Serum anti‐LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases

Delayed Appearance of Brain Magnetic Resonance Imaging Abnormalities in a Patient with Glial Fibrillary Acidic Protein Astrocytopathy

Temporal Changes in Brain Perfusion in a Patient with Myoclonus and Ataxia Syndrome Associated with COVID-19

Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis

Response to “regarding the article ‘Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis’”

Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis optica

Split hand and motor axonal hyperexcitability in spinal and bulbar muscular atrophy

Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD

Efficacy of high-dose intravenous methylprednisolone therapy for ocular myasthenia gravis

Serum high mobility group box 1 is upregulated in myasthenia gravis

Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis

Frontal deficits and atrophy in a patient with familial encephalopathy with neuroserpin inclusion bodies detected by single-case voxel-based morphometry: a case report

Geographical differences in preventative therapies for neuromyelitis optica spectrum disorder

Soluble CD40 ligand disrupts the blood–brain barrier and exacerbates inflammation in experimental autoimmune encephalomyelitis

Suchergebnisse filtern